BOOSTING THE SYSTEMIC AND IN SITU CD4+ T-CELL RESPONSES TO MALIGNANT GLIOMA BY ONCOLYTIC HSV VIROTHERAPY

$527,162FY2018Department of the ArmyDOD

University Of Alabama At Birmingham, Birmingham AL

Investigators